Whitehawk Therapeutics (WHWK) Capital Expenditures Growth (1y) (2017 - 2025)
Whitehawk Therapeutics (WHWK) Capital Expenditures Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 143.40% |
| 10 | Whitehawk Therapeutics | 258.25 Mn | 47.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 66.48% |
| Jun 30, 2025 | -53.03% |
| Mar 31, 2025 | 17.39% |
| Dec 31, 2024 | 1,784.17% |
| Sep 30, 2024 | -79.61% |
| Jun 30, 2024 | 974.24% |
| Mar 31, 2024 | -135.66% |
| Dec 31, 2023 | -131.25% |
| Sep 30, 2023 | -349.51% |
| Jun 30, 2023 | -45.23% |
| Mar 31, 2023 | 1,582.61% |
| Dec 31, 2022 | 179.83% |
| Dec 31, 2021 | -758.55% |
| Dec 31, 2020 | -5,602,400.00% |
| Sep 30, 2020 | 59.47% |
| Dec 31, 2019 | -100.01% |
| Sep 30, 2019 | -79.50% |
| Mar 31, 2019 | 1,233.05% |
| Dec 31, 2018 | 263.22% |
| Mar 31, 2018 | 284.87% |